Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma

Investigational New Drugs
Norimichi AkiyamaTakafumi Suda

Abstract

Background Optimal maintenance therapy for lung squamous cell carcinoma (SCC) has not been established. The aim of this study was to evaluate the efficacy and safety of switch maintenance therapy with S-1, an oral fluoropyrimidine, after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in chemotherapy-naïve patients with advanced SCC. Methods Chemotherapy-naïve patients with advanced SCC received induction therapy with four cycles of carboplatin (at an area under the curve of 6, day 1 of a 28-day cycle) and nab-paclitaxel (100 mg/kg, days 1, 8, and 15). Patients who achieved disease control after induction therapy received maintenance therapy with S-1 (80 mg/m2, days 1-14 of a 21-day cycle) until disease progression or unacceptable toxicity. The primary endpoint was progression-free survival (PFS) from the start of maintenance therapy. Results Seventy-two patients with SCC were enrolled to the study. After four cycles of induction therapy, 35 (48.6%) patients achieved disease control, and 31 (43.1%) of these patients received maintenance therapy. Median PFS from the start of maintenance therapy was 3.0 months (95% confidence interval: 2.1-3.8 months). The most common toxicities of gr...Continue Reading

References

Nov 26, 1998·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·M L Janssen-HeijnenJ W Coebergh
May 12, 2004·Nature Reviews. Drug Discovery·Napoleone FerraraWilliam Novotny
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Nov 6, 2007·The New England Journal of Medicine·Shinichi SakuramotoUNKNOWN ACTS-GC Group
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giorgio Vittorio ScagliottiDavid Gandara
Dec 17, 2008·Molecular Cancer Therapeutics·Jie Ma, David J Waxman
Mar 3, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jong-Mu SunKeunchil Park
Nov 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Isamu OkamotoKazuhiko Nakagawa
Dec 22, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·David E GerberYang Xie
Feb 24, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Takayuki ShiroyamaIchiro Kawase
Apr 25, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K KubotaUNKNOWN Tokyo Cooperative Oncology Group
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Apr 9, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E OkiY Maehara
Jun 15, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Mark A SocinskiNick Thatcher
Sep 25, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S NovelloUNKNOWN ESMO Guidelines Committee
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Jun 20, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Seiji NihoKoichi Goto
Aug 15, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nasser HannaGregory Masters
Apr 17, 2018·The New England Journal of Medicine·Matthew D HellmannLuis Paz-Ares
Apr 17, 2018·The New England Journal of Medicine·Leena GandhiUNKNOWN KEYNOTE-189 Investigators
Oct 4, 2018·The New England Journal of Medicine·Luis Paz-AresUNKNOWN KEYNOTE-407 Investigators

❮ Previous
Next ❯

Citations

May 30, 2019·Pathology, Research and Practice·Shigehiro ItoHironobu Sasano

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.